141 related articles for article (PubMed ID: 9222688)
1. Urinary excretion of prostaglandins and renal function after hepatic resection.
Matsumata T; Yamamoto K; Shirabe K; Shimada M; Sugimachi K; Takesue F; Muto Y; Ikeda T
Hepatogastroenterology; 1997; 44(15):774-8. PubMed ID: 9222688
[TBL] [Abstract][Full Text] [Related]
2. Renal function after elective hepatic resection.
Matsumata T; Taketomi A; Fujiwara Y; Shimada M; Takenaka K; Sugimachi K
Hepatogastroenterology; 1996; 43(9):602-7. PubMed ID: 8799403
[TBL] [Abstract][Full Text] [Related]
3. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
[TBL] [Abstract][Full Text] [Related]
4. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of vasoactive substances in chronic renal failure.
Cantaro S; Milan Manani S; Marcon R; Bonfante L; Masiero M; D'Angelo A; Calò L
Clin Nephrol; 2001 May; 55(5):393-9. PubMed ID: 11393385
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome.
Zipser RD; Kronborg I; Rector W; Reynolds T; Daskalopoulos G
Gastroenterology; 1984 Dec; 87(6):1228-32. PubMed ID: 6593268
[TBL] [Abstract][Full Text] [Related]
7. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
8. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
Niwa T; Maeda K; Shibata M; Yamada K
Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971
[TBL] [Abstract][Full Text] [Related]
9. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC
J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
[TBL] [Abstract][Full Text] [Related]
10. A high plasma prostaglandin to thromboxane ratio protects against renal ischemia.
Kaufman RP; Anner H; Kobzik L; Valeri CR; Shepro D; Hechtman HB
Surg Gynecol Obstet; 1987 Nov; 165(5):404-9. PubMed ID: 3672299
[TBL] [Abstract][Full Text] [Related]
11. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites.
Gentilini P; Laffi G; Meacci E; La Villa G; Cominelli F; Pinzani M; Buzzelli G
Gastroenterology; 1988 Jun; 94(6):1470-7. PubMed ID: 3360268
[TBL] [Abstract][Full Text] [Related]
12. [Insulin resistance and effects of intravenous acute saline load on renal production of prostaglandin I2 and thromboxane A2 in salt-sensitive hypertensive patients].
Ye T; Liu ZQ; Liu J; Zhu DJ; Zheng Y
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):102-5. PubMed ID: 15684012
[TBL] [Abstract][Full Text] [Related]
13. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
[TBL] [Abstract][Full Text] [Related]
14. [Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure].
Lao XM; Zhang YQ; Lin XJ; Guo RP; Chen MS; Yuan YF; Li JQ; Li GH
Ai Zheng; 2005 Mar; 24(3):337-40. PubMed ID: 15757537
[TBL] [Abstract][Full Text] [Related]
15. Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites.
Pinzani M; Laffi G; Meacci E; La Villa G; Cominelli F; Gentilini P
Gastroenterology; 1988 Oct; 95(4):1081-7. PubMed ID: 3165896
[TBL] [Abstract][Full Text] [Related]
16. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
17. The role of prostanoid in hepatic damage during hepatectomy.
Shirabe K; Takenaka K; Yamamoto K; Kitamura M; Itasaka H; Matsumata T; Shimada M; Sugimachi K
Hepatogastroenterology; 1996; 43(9):596-601. PubMed ID: 8799402
[TBL] [Abstract][Full Text] [Related]
18. Renal haemodynamics, sodium and water reabsorption during continuous intravenous infusion of recombinant interleukin-2.
Geertsen PF; von der Maase H; Olsen NV; Fogh-Andersen N; Nielsen SL; Leyssac PP
Clin Sci (Lond); 1998 Jul; 95(1):73-81. PubMed ID: 9662488
[TBL] [Abstract][Full Text] [Related]
19. Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis.
Longhofer SL; Frisbie DD; Johnson HC; Culham CA; Cooley AJ; Schultz KT; Grauer GF
Am J Vet Res; 1991 Mar; 52(3):480-7. PubMed ID: 1827969
[TBL] [Abstract][Full Text] [Related]
20. Renal function and urinary prostanoid excretions in salt-depleted women: comparative effects of enalapril and indomethacin treatments.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 1999 Feb; 60(2):87-93. PubMed ID: 10328327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
